Antigen discovery

Antigen discovery

Determining antigenic targets for vaccines using traditional methods can be time-consuming.  Protein microarray is a multiplex alternative that offers significant advantages in throughput, enabling researchers to simplify screening experiments, and speed up discovery of antigenic vaccine targets.


Application note

Reproducible printing is crucial to producing reliable protein arrays.  Arrayjet's application note demonstrates printing consistency using a Marathon microarray spotter.

Assessment Of Printing Reproducibility.pdf

Selected publications 

KILchip v1.0: A novel Plasmodium falciparum erozoite protein microarray to facilitate malaria vaccine candidate prioritization
G. Kamuyu, J. Tuju, R. Kimathi, K. Mwai, J. Mburu, N. Kibinge, M. Chong Kwan, S. Hawkings, R. Yaa, E. Chepsat, J. M. Njunge, T. Chege, F. Guleid, M. Rosenkranz, C. K. Kariuki, R. Frank, S. M. Kinyanjui, L. M. Murungi, P. Bejon, A. Färnert, K. K. A. Tetteh, J. G. Beeson, D. J. Conway, K. Marsh, J. C. Rayner and F. H. A. Osier
Frontiers in Immunology

Retrospective identification of a broad IgG repertoire differentiating patients with S. aureus skin and soft tissue infections from controls
F. Rigat, E. Bartolini, M. Dalsass, N. Kumar, S. Marchi, P. Speziale, D. Maione, L. Chen, M. R. Romano, M. Alegre, F. Bagnoli, R. S. Daum, and M. Z. David
Frontiers in Immunology


Testimonials

"The combination of an excellent product in their microarray printers and a responsive technical support team to assist with bespoke solutions to individual project needs were two of the many attributes that attracted us to work with Arrayjet. At every step of the design of an in-house microarray chip, we had at our disposal a dedicated team of application specialists who were very cordial and available to respond to our many queries. It was on the back of this excellent support that we eventually purchased one of their microarray printers and we have continued to enjoy excellent technical training on the instrument and engineering support."

Dr. James Tuju, Principal Investigator, KEMRI Wellcome Trust, Kenya